A Trial of Cadonilimab Plus Regorafenib in Patients With Hepatocellular Carcinoma Who Failed Camrelizumab Combined With Apatinib
Clinical trial NCT06280105 · RECRUITING
Trial details
- NCT number
- NCT06280105
- Sponsor
- Meng Chao Hepatobiliary Hospital of Fujian Medical University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-31
- Primary completion
- 2026-03-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.